These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 24103227)

  • 1. Baseline characteristics and effects of ten years of growth hormone (GH) replacement therapy in adults previously treated with pituitary irradiation.
    Elbornsson M; Götherström G; Bengtsson BÅ; Johannsson G; Svensson J
    Growth Horm IGF Res; 2013 Dec; 23(6):249-55. PubMed ID: 24103227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline characteristics and effects of growth hormone therapy over two years in younger and elderly adults with adult onset GH deficiency.
    Franco C; Johannsson G; Bengtsson BA; Svensson J
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4408-14. PubMed ID: 16940452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease.
    Johannsson G; Sunnerhagen KS; Svensson J
    Clin Endocrinol (Oxf); 2004 May; 60(5):550-9. PubMed ID: 15104557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
    Tanriverdi F; Unluhizarci K; Kula M; Guven M; Bayram F; Kelestimur F
    Growth Horm IGF Res; 2005 Jun; 15(3):231-7. PubMed ID: 15921942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline characteristics and the effects of two years of growth hormone (GH) replacement therapy in adults with GH deficiency previously treated for acromegaly.
    Norrman LL; Johannsson G; Sunnerhagen KS; Svensson J
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2531-8. PubMed ID: 18397981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
    Feldt-Rasmussen U; Wilton P; Jonsson P; ;
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
    Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
    Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
    Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone (GH) replacement therapy in GH deficient adults: predictors of one-year metabolic and clinical response.
    Svensson J; Finer N; Bouloux P; Bevan J; Jonsson B; Mattsson AF; Lundberg M; Harris PE; Koltowska-Häggström M; Monson JP;
    Growth Horm IGF Res; 2007 Feb; 17(1):67-76. PubMed ID: 17223598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS - Pfizer International Metabolic Database.
    Kelestimur F; Jonsson P; Molvalilar S; Gomez JM; Auernhammer CJ; Colak R; Koltowska-Häggström M; Goth MI
    Eur J Endocrinol; 2005 Apr; 152(4):581-7. PubMed ID: 15817914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults.
    van Varsseveld NC; van Bunderen CC; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
    Pituitary; 2016 Aug; 19(4):381-90. PubMed ID: 27048484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GH replacement improves quality of life and metabolic parameters in cured acromegalic patients with growth hormone deficiency.
    Giavoli C; Profka E; Verrua E; Ronchi CL; Ferrante E; Bergamaschi S; Sala E; Malchiodi E; Lania AG; Arosio M; Ambrosi B; Spada A; Beck-Peccoz P
    J Clin Endocrinol Metab; 2012 Nov; 97(11):3983-8. PubMed ID: 22904173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement.
    Esposito V; Di Biase S; Lettiero T; Labella D; Simeone R; Salerno M
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):607-11. PubMed ID: 15521964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of long-term GH replacement therapy on cardiovascular outcomes in isolated GH deficiency compared with multiple pituitary hormone deficiencies: a sub-analysis from the Dutch National Registry of Growth Hormone Treatment in Adults.
    van Bunderen CC; van den Dries CJ; Heymans MW; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
    Eur J Endocrinol; 2014 Aug; 171(2):151-60. PubMed ID: 24801587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency.
    Götherström G; Bengtsson BA; Bosaeus I; Johannsson G; Svensson J
    Eur J Endocrinol; 2007 Jan; 156(1):55-64. PubMed ID: 17218726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of 5 years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone-deficient adults.
    Cenci MC; Conceição FL; Soares DV; Spina LD; Brasil RR; Lobo PM; Michmacher E; Vaisman M
    Metabolism; 2008 Jan; 57(1):121-9. PubMed ID: 18078869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of GH treatment in GH-deficient adults on adiponectin, leptin and pregnancy-associated plasma protein-A.
    Joaquin C; Aguilera E; Granada ML; Pastor MC; Salinas I; Alonso N; Sanmartí A
    Eur J Endocrinol; 2008 Apr; 158(4):483-90. PubMed ID: 18362295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postprandial triglyceride profile after a standardized oral fat load is altered in growth hormone (GH)-deficient adult patients and is not improved after short-term GH replacement therapy.
    Perotti M; Caumo A; Brunani A; Cambiaghi N; Casati M; Scacchi M; Perra S; Rocco C; Mancia G; Grassi G; Cavagnini F; Pincelli AI
    Clin Endocrinol (Oxf); 2012 Nov; 77(5):721-7. PubMed ID: 22519803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board.
    Bengtsson BA; Abs R; Bennmarker H; Monson JP; Feldt-Rasmussen U; Hernberg-Stahl E; Westberg B; Wilton P; Wüster C
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3929-35. PubMed ID: 10566630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.